Secor Capital Advisors’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-25,341
Closed -$815K 534
2018
Q4
$815K Sell
25,341
-8,567
-25% -$323K 0.11% 256
2018
Q3
$1.46M Buy
33,908
+21,623
+176% +$1.02M 0.16% 198
2018
Q2
$566K Buy
+12,285
New +$544K 0.05% 366
2018
Q1
Sell
-7,008
Closed -$235K 610
2017
Q4
$235K Buy
+7,008
New +$249K 0.01% 434
2017
Q2
Sell
-8,781
Closed -$247K 555
2017
Q1
$247K Sell
8,781
-3,505
-29% -$98.9K 0.03% 413
2016
Q4
$360K Sell
12,286
-20,962
-63% -$572K 0.04% 386
2016
Q3
$904K Sell
33,248
-50,886
-60% -$1.15M 0.1% 272
2016
Q2
$1.57M Buy
+84,134
New +$1.75M 0.2% 156

Other funds holding PAHC

Secor Capital Advisors's PAHC Position: Q1 2019 in Review

Secor Capital Advisors sold out of Phibro Animal Health (PAHC) in Q1 2019, closing a stake of 25,341 shares — an estimated $815K sold.

Secor Capital Advisors first reported a position in PAHC in Q2 2016 and held it in 8 quarters. The position peaked at $1.57M in Q2 2016. 176 funds tracked by Wall St. Rank hold PAHC as of Q1 2019.

  • Secor Capital Advisors reported no remaining Phibro Animal Health position as of Q1 2019 after selling out during the quarter.
  • Secor Capital Advisors sold 25,341 Phibro Animal Health shares in Q1 2019, an estimated $815K.
  • Secor Capital Advisors first reported a position in Phibro Animal Health in Q2 2016 and held it in 8 quarters.
  • Secor Capital Advisors's Phibro Animal Health position peaked at $1.57M in Q2 2016.
  • 176 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2019.

Based on Secor Capital Advisors's 13F filing for Q1 2019, filed 15 May 2019.